Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2025-12-25 @ 4:12 AM
NCT ID: NCT01417520
Eligibility Criteria: * INCLUSION CRITERIA: * ECD patients of any gender and ethnicity age 2-80 years are eligible to enroll in this protocol. * Patients will be diagnosed as having ECD based upon pathologic evaluations of affected organs. * Any child older than 2 years with confirmed ECD by pathology will be enrolled in our study since childhood cases are so rare. The child must be clinically stable prior to visiting the NIHCC. * Patients that agree to be part of this research study are expected to undergo the evaluations and testing of this protocol. EXCLUSION CRITERIA: * Patients will be excluded if they have a suspected diagnosis of ECD not confirmed by biopsy or another form of histiocytosis. --If the patients cannot travel to the NIH because of their medical condition, they can still participate in our study by submitting tissue and blood for research purposes after consent has been obtained and diagnosis of ECD has been confirmed through tissue-biopsy evaluation. This exception applies to all patients aged 2-80 years. * Children under age two years are excluded because there is no urgency for a very early diagnosis and care is more readily provided to older children at the Clinical Center. * Pregnant women will not take part in this study because of the fetal risks, unless they will be participating by only submitting samples of previously collected tissue. We will not encourage pregnant women to undergo affected organ surgery or biopsy to participate in this study, unless clinically indicated and recommended by their private physicians.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 2 Years
Maximum Age: 80 Years
Study: NCT01417520
Study Brief:
Protocol Section: NCT01417520